Fisher & Paykel Healthcare Board Chairman to retire in 2020

News Release
STOCK EXCHANGE LISTINGS: NEW ZEALAND (FPH), AUSTRALIA (FPH)

Fisher & Paykel Healthcare Board Chairman Tony Carter to retire in 2020
Auckland, New Zealand, 27 November 2019 - Fisher & Paykel Healthcare Board Chairman Tony
Carter has announced his intention to retire with effect from the close of the company’s annual
shareholders’ meeting in August next year. Current director Scott St John has been elected by the
Board to succeed Mr Carter as chairman.

Mr Carter has held the role of chairman at Fisher & Paykel Healthcare since April 2012 after joining
the Board in 2010. His retirement was signalled to the Board earlier this year and it is generally
expected that the company’s non-executive directors will serve for a period of approximately nine
years.

“I am delighted that Scott will succeed me, and he has the unanimous support of his fellow
directors. As the chairman of our Audit & Risk Committee, Scott has been a strong leader with
excellent corporate governance and commercial skills,” Mr Carter said.

Scott St John joined the board of Fisher & Paykel Healthcare in 2015 as an independent director.
He is currently Chancellor of the University of Auckland and a director of Mercury Limited, the
NEXT Foundation and Fonterra Cooperative Group Limited. He also held the role of Chief
Executive Officer of First NZ Capital, now known as Jarden, from 2002 to March 2017.

Scott St John acknowledged the great responsibility that goes with being elected to lead the Fisher
& Paykel Healthcare Board of Directors on behalf of all its stakeholders.

“It has been my privilege to serve on the Board of Fisher & Paykel Healthcare for the past four
years, working alongside an exceptional team, led by Tony, including my fellow Board members
and the management team. Fisher & Paykel Healthcare possesses a special culture and an
unwavering commitment to understanding and meeting patient needs. I look forward to continuing
to contribute to the development, growth and success of this remarkable company.”

The company is undertaking a search for another independent director to replace Mr Carter and
will update the market in due course. Mr Carter’s outstanding contribution to Fisher & Paykel
Healthcare will be formally acknowledged at the annual shareholders' meeting next year.

Ends

About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and
systems for use in respiratory care, acute care, surgery and the treatment of obstructive sleep
apnea. The company’s products are sold in over 120 countries worldwide. For more information
about the company, visit our website www.fphcare.com.

Contact:
Investors:
Hayden Brown
Investor Relations Manager
hayden.brown@fphcare.co.nz
+64 27 807 8073
Media:
Karen Knott
Senior Communications Manager
karen.knott@fphcare.co.nz
+64 21 713 911